Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) FCF Margin (2016 - 2025)

Historic FCF Margin for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 2.08%.

  • Nephros' FCF Margin rose 197900.0% to 2.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.12%, marking a year-over-year increase of 303900.0%. This contributed to the annual value of 3.92% for FY2024, which is 92000.0% down from last year.
  • Per Nephros' latest filing, its FCF Margin stood at 2.08% for Q3 2025, which was up 197900.0% from 22.49% recorded in Q2 2025.
  • In the past 5 years, Nephros' FCF Margin registered a high of 33.49% during Q4 2024, and its lowest value of 84.81% during Q1 2022.
  • Its 5-year average for FCF Margin is 8.58%, with a median of 7.06% in 2022.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 1039000bps in 2021, then crashed by -819600bps in 2022.
  • Nephros' FCF Margin (Quarter) stood at 12.35% in 2021, then skyrocketed by 38bps to 7.62% in 2022, then dropped by -10bps to 8.39% in 2023, then soared by 499bps to 33.49% in 2024, then crashed by -94bps to 2.08% in 2025.
  • Its last three reported values are 2.08% in Q3 2025, 22.49% for Q2 2025, and 6.6% during Q1 2025.